Hang Lung Ppt (0101) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Hang Lung Ppt HK$4.74, price HK$6.53, upside -27.4%, quality 62 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Hang Lung Ppt for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range HK$4.64 – HK$15.17 · fair‑value band HK$0.9480 – HK$8.39 · the HK$6.53 price screens above the HK$4.74 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Hang Lung Ppt in your weekly email
Every Wednesday you see whether Hang Lung Ppt is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Hang Lung Properties Limited, an investment holding company, operates as a property developer in Hong Kong and Mainland China. It operates through Property Leasing, Hotels, and Property Sales segments.
Show more
Hang Lung Properties Limited, an investment holding company, operates as a property developer in Hong Kong and Mainland China. It operates through Property Leasing, Hotels, and Property Sales segments. The company is involved in property development, sale, and leasing, as well as car park management and property management; develops, holds, and manages commercial complexes; and customer engagement business, including hello Hang Lung mall rewards program and House 66. Its properties include a portfolio of retail, office, residential, and serviced apartments. The company was incorporated in 1949 and is headquartered in Central, Hong Kong. Hang Lung Properties Limited operates as a subsidiary of Hang Lung Group Limited.
Stock analysis
Hang Lung Ppt (0101) currently trades at HK$6.53, while our model-based Fair Value estimate is HK$4.74, implying the stock looks roughly 37.8% overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of HK$17.35 per share, and 6 of the 16 models we run sit above the HK$6.53 price.
Bear case: the Dividend Discount group reads lowest at HK$1.53, and 10 of the 16 models stay below the price. Evidence for this calculation is low.
Scenario range: HK$0.9480 (bear) to HK$8.39 (bull), the price of HK$6.53 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Real Estate sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Hang Lung Ppt reported revenue of HK$10.0B in FY2025 versus HK$10.3B in FY2021, a compound −0.9%/yr. Reported net income was HK$1.8B in FY2025, compounding −17.3%/yr from FY2021.
Key figures
Market cap HK$33.1B (≈ $4.2B) · P/E ratio 19.9 · P/S ratio 3.60 · Dividend yield 8.0% · Net margin 18.1% · Return on equity 1.5% · Return on assets (EBIT) 2.9% · Operating margin 48.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 32% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −37% fair-value upside, at −27%, 0101 screens cheaper than that median.
Fair Value models
Bear HK$0.9480Fair Value HK$4.74Bull HK$8.39
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.74/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.9%
Revenue growth 31 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.0%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+5.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−2.1%
Dividend (yield on the price)8.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−20% vs −12%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.66% → 59%
Start year 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+10.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.3%
Yearly sales growth analysts expect, extended to five years.
After inflation (Hong Kong: IMF forecast 2.1% a year to 2030, 1.8% from 2016 to 2025) that is about +8.1% a year for the price and +2.2% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 546 stocks
Beats the industry median on 9/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score64 · Top 25%
Fair Value upside−28% · Below median
Profitability
Return on equity (TTM)1% · Below median
Return on assets2% · Above median
Net margin (TTM)19% · Above median
Operating margin (TTM)48% · Above median
Growth and dividend
Revenue growth23% · Top 25%
Dividend yield (TTM)8.0% · Top 25%
Balance sheet
Debt / equity0.36× · Above median
Valuation Multiplesvs Real Estate Services median · lower = cheaper
P/E (TTM)19.9× · Pricier than median
P/B0.25× · Cheapest 25%
P/S (TTM)3.87× · Pricier than median
P/FCF1.4× · Cheaper than median
EV/EBITDA16.2× · Pricier than median
PEG0.29× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 38
FUTURE (revenue growth)100· sector 12
PAST (return on equity)6· sector 16
HEALTH (low debt)82· sector 83
DIVIDEND (yield)100· sector 65
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Hang Lung Ppt (0101) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of HK$4.74 versus a price of HK$6.53, about −27% upside (overvalued).
What is the fair value of 0101?
Our model-based fair value for Hang Lung Ppt is HK$4.74 (as of Sep 24, 2026), built from audited fundamentals. The current price: HK$6.53.
What is the quality score of 0101?
Hang Lung Ppt has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hang Lung Ppt (0101)?
Our model-based price target is the fair value of HK$4.74 (as of Sep 24, 2026) from 16 valuation models. Cautious scenario HK$0.9480, optimistic scenario HK$8.39. It is a calculation from audited fundamentals, not an analyst target.
What is the Hang Lung Ppt stock forecast for 2026?
Our models put fair value at HK$4.74, about −27% upside versus a price of HK$6.53 (overvalued). Cautious scenario HK$0.9480, optimistic scenario HK$8.39. The calculation is refreshed regularly with new filings.
What is the revenue of Hang Lung Ppt (0101)?
Hang Lung Ppt reported trailing-twelve-month revenue of about HK$11.1B (latest available figure, as of Sep 24, 2026).
Does Hang Lung Ppt pay a dividend?
Hang Lung Ppt currently shows a dividend yield of about 7.96% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Hang Lung Ppt (0101)?
For today's price to be fair in a discounted-cash-flow model, Hang Lung Ppt would have to grow free cash flow by +10.4 % per year for five years (discount rate 9.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.1 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 0101 use?
Our models discount Hang Lung Ppt at 9.6 %: a base by market capitalisation (mid), damped by beta 0.75, country premium for Hong Kong. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Hang Lung Ppt that is +10.4 % per year a year over ten years, using the same discount rate (9.6 %) and the same formula as our fair value.
How much growth has Hang Lung Ppt (0101) delivered so far?
Over the past 5 years revenue at Hang Lung Ppt grew +2.1 % a year. The price currently implies +10.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Hang Lung Ppt (0101) growing?
The median revenue growth in the sector is +1.8 % a year. That is the yardstick for the growth priced into Hang Lung Ppt (+10.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Hang Lung Ppt (0101)?
The free-cash-flow yield on the price is 11.47 %: that much free cash flow Hang Lung Ppt produces per unit of market value. When it exceeds the discount rate of our models (9.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Hang Lung Ppt (0101)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hang Lung Ppt it is HK$4.74 per share (as of Sep 24, 2026), against a price of HK$6.53. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Hang Lung Ppt stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0101 trades above its calculated fair value: price HK$6.53, fair value HK$4.74, a gap of about −27% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0101?
No. The price is what the market pays today (HK$6.53); the fair value is what the company's own numbers justify (HK$4.74). For Hang Lung Ppt the two are HK$1.79 per share apart. That gap is exactly why we show both numbers side by side.
How much is Hang Lung Ppt worth?
The market values Hang Lung Ppt at about HK$33.1B (market capitalisation, as of Sep 24, 2026). Per share that is HK$6.53; our models calculate a fair value of HK$4.74 per share.
What do the bullish and bearish scenarios say about 0101?
Our models span a range for Hang Lung Ppt: cautious scenario HK$0.9480, base HK$4.74, optimistic HK$8.39 per share (as of Sep 24, 2026, price HK$6.53). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 0101?
Hang Lung Ppt trades at a price-to-earnings ratio of 19.9 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$4.74 is built from several models across several years. Other multiples: PEG 0.3, P/B 0.3, P/S 3.9, EV/EBITDA 16.2.
What is the PEG ratio of 0101?
The PEG ratio of Hang Lung Ppt is 0.29 (P/E divided by earnings growth, as of Sep 24, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Hang Lung Ppt (0101)?
Balance-sheet figures for Hang Lung Ppt (as of Sep 24, 2026): return on equity 1.5%, debt of 0.36 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is 0101 from its 52-week high?
Hang Lung Ppt trades at HK$6.53, about 32% below its 52-week high of HK$9.67 and at the low of HK$6.53 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of HK$4.74 is for.
Which stocks are comparable to Hang Lung Ppt?
From the same area (Real Estate) we also value Vingroup Joint Stock Company, CBRE Group, Vonovia SE, Cellnex Telecom, S.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hang Lung Ppt stock attractive at the current price?
The data as of Sep 24, 2026: price HK$6.53, calculated fair value HK$4.74 (−27%), Quality Score 62/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0101 calculated?
We run Hang Lung Ppt through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$4.74, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Hang Lung Ppt itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hang Lung Ppt (0101)?
The closing price on Sep 24, 2026 was HK$6.53. Our model-based fair value is HK$4.74, about −27% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hang Lung Ppt right now?
The model range is unusually wide (HK$0.9480 to HK$8.39). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Where does the earnings growth of Hang Lung Ppt (0101) come from?
Earnings per share at Hang Lung Ppt grew −11.6 % a year from 2014 to 2025. Broken into its drivers: revenue per share −2.9 %, EBIT margin −1.7 %, tax rate −3.0 %, residual (interest, one-offs) −4.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Hang Lung Ppt
How large is the market capitalisation of Hang Lung Ppt (0101)?
The market capitalisation of Hang Lung Ppt is HK$33.1B (≈ $4.2B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hang Lung Ppt (0101)?
The price-to-sales ratio of Hang Lung Ppt is 3.60 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Hang Lung Ppt (0101)?
The dividend yield of Hang Lung Ppt is 8.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hang Lung Ppt (0101)?
The net margin of Hang Lung Ppt is 18.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hang Lung Ppt (0101)?
The return on equity (ROE) of Hang Lung Ppt is 1.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hang Lung Ppt (0101)?
On an EBIT basis the return on assets of Hang Lung Ppt is 2.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hang Lung Ppt (0101)?
The operating margin of Hang Lung Ppt is 48.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hang Lung Ppt (0101)?
Revenue at Hang Lung Ppt is growing +23.0% versus a year earlier (3y avg −1.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hang Lung Ppt (0101)?
Earnings per share at Hang Lung Ppt are growing −21.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Hang Lung Ppt (0101) carry?
The net debt of Hang Lung Ppt is HK$47.8B (fiscal year 2025, ≈ 12.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Hang Lung Ppt in the live analysis
One click puts Hang Lung Ppt on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
